The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Efficacy and safety of ponatinib in heavily pretreated leukemia patients in the PACE trial: 3-year results.
 
Jorge E. Cortes
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
 
Dong Goo Kim
Research Funding - ARIAD
 
Javier Pinilla-Ibarz
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Speakers' Bureau - Bristol-Myers Squibb; Pfizer; Teva
Research Funding - ARIAD; Novartis
 
Philipp D. Le Coutre
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Ronald Paquette
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
 
Charles Chuah
No Relationships to Disclose
 
Franck E. Nicolini
No Relationships to Disclose
 
Jane Apperley
Honoraria - ARIAD; Bristol-Myers Squibb; MSD; Novartis; Pfizer
Research Funding - Novartis
 
Hanna Jean Khoury
Honoraria - ARIAD
Research Funding - ARIAD
 
Moshe Talpaz
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Research Funding - ARIAD; Incyte; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - ARIAD; Incyte; Novartis; Pfizer
 
John F. DiPersio
Honoraria - Dava Oncology; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Fate Therapeutics; GlaxoSmithKline; Idera; Juno Therapeutics; Macrogenics; SERVIER
Research Funding - Amphivena Therapeutics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Dava Oncology; Fate Therapeutics; GlaxoSmithKline; Idera; Juno Therapeutics; Macrogenics; Merck Sharp & Dohme; Sanofi; SERVIER
 
Michele Baccarani
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Stephanie Lustgarten
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Frank G. Haluska
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Francois Guilhot
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Novartis
 
Michael W.N. Deininger
Honoraria - ARIAD; Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Andreas Hochhaus
Research Funding - ARIAD
 
Timothy P. Hughes
No Relationships to Disclose
 
Neil P. Shah
Research Funding - ARIAD; Bristol-Myers Squibb; Daiichi Sankyo; Pfizer; Plexxikon
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)